About bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine
bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine (PubChem CID 161163554) has the molecular formula C90H89Cl2F3N36O7
and a molecular weight of 1914.85 g/mol. Its IUPAC name is bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine.
Frequently Asked Questions
What is the IUPAC name of bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine?
The IUPAC name of bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine (CID 161163554) is bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine.
What is the SMILES notation for bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine?
The canonical SMILES for bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine is CC1C(c2cn[nH]c2)OCCN1c1ccnc(-c2cnc3cnc(C(F)(F)F)cn23)n1.CC1CN(c2ccnc(-c3cnc4cnc(Cl)cn34)n2)CC(c2cn[nH]c2)O1.CC1CN(c2ccnc(-c3cnc4cnc(Cl)cn34)n2)CC(c2cn[nH]c2)O1.NC(=O)c1cn2c(-c3cccc(N4CCC(O)CC4)n3)cnc2cn1.NC(=O)c1cn2c(-c3cccc(N4CCCC(CO)C4)n3)cnc2cn1.
What is the InChIKey of bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine?
The InChIKey is UQFSKCGTCVYPOK-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H17F3N8O.2C18H17ClN8O.C18H20N6O2.C17H18N6O2/c1-11-17(12-6-26-27-7-12)31-5-4-29(11)15-2-3-23-18(28-15)13-8-25-16-9-24-14(10-30(13)16)19(20,21)22;2*1-11-8-26(9-14(28-11)12-4-23-24-5-12)16-2-3-20-18(25-16)13-6-22-17-7-21-15(19)10-27(13)17;19-18(26)14-10-24-15(7-21-17(24)8-20-14)13-4-1-5-16(22-13)23-6-2-3-12(9-23)11-25;18-17(25)13-10-23-14(8-20-16(23)9-19-13)12-2-1-3-15(21-12)22-6-4-11(24)5-7-22/h2-3,6-11,17H,4-5H2,1H3,(H,26,27);2*2-7,10-11,14H,8-9H2,1H3,(H,23,24);1,4-5,7-8,10,12,25H,2-3,6,9,11H2,(H2,19,26);1-3,8-11,24H,4-7H2,(H2,18,25).
What are the key properties of bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine?
bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine has a molecular weight of 1914.85 g/mol, XLogP of 9.90, 16 rotatable bonds, 7 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for bis(4-[2-(6-chloroimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-2-methyl-6-(1H-pyrazol-4-yl)morpholine);3-[6-[3-(hydroxymethyl)piperidin-1-yl]-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-[6-(4-hydroxypiperidin-1-yl)-2-pyridinyl]imidazo[1,2-a]pyrazine-6-carboxamide;3-methyl-2-(1H-pyrazol-4-yl)-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine is sourced from PubChem (CID 161163554), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).